Bain Capital Life Sciences Fund II, L.P.

Related Filers (22)

Other (14)

13F-NT
Tuesday, 2/13/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
D
Tuesday, 4/9/2019
Exempt (Private) Offering
Show More

Ownership (28)

SC 13G/A
Tuesday, 2/13/2024
Syros Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 1/12/2024
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 12/29/2023
NewAmsterdam Pharma Co N.V.: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 10/20/2023
Nuvalent, Inc.: Major Shareholders
SC 13D/A
Wednesday, 7/19/2023
Savara Inc: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Syros Pharmaceuticals, Inc.: Major Shareholders
3
Monday, 12/5/2022
Solid Biosciences Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 11/3/2022
Nuvalent, Inc.: Major Shareholders
SC 13D/A
Wednesday, 5/11/2022
Mersana Therapeutics, Inc.: Major Shareholders
SC 13D/A
Thursday, 4/14/2022
Mersana Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Xilio Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Syros Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Tuesday, 2/8/2022
Mersana Therapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 1/3/2022
Mersana Therapeutics, Inc.: Major Shareholders
4
Friday, 12/10/2021
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 11/5/2021
Xilio Therapeutics, Inc.: Major Shareholders
3
Friday, 11/5/2021
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 9/24/2021
Atea Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Friday, 9/3/2021
Atea Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Wednesday, 8/4/2021
Nuvalent, Inc.: Major Shareholders
SC 13D/A
Wednesday, 3/17/2021
Savara Inc: Major Shareholders
SC 13D/A
Tuesday, 1/12/2021
Mersana Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 12/14/2020
Syros Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Thursday, 11/12/2020
Atea Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Thursday, 8/13/2020
ARYA Sciences Acquisition Corp III: Major Shareholders
SC 13G
Monday, 7/20/2020
Therapeutics Acquisition Corp.: Major Shareholders
SC 13D
Friday, 4/17/2020
Mersana Therapeutics, Inc.: Major Shareholders
SC 13D
Monday, 12/30/2019
Savara Inc: Major Shareholders
Show More